Biotech · Private company · Las Vegas, NV, US
Regenerex Pharma, Inc.
SEC CIK 0001357878
Track this companyFree. Adds Regenerex Pharma, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
SEC filings12
- 8-K · CURRENT REPORTSEC EDGAR · filed Sep 4, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Sep 1, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Jun 22, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Jun 11, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed May 6, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Apr 2, 2026 · fetched Nov 12, 2026
- 10-Q · QUARTERLY REPORT FOR THE PERIOD ENDED SEPTEMBER 30, 2025SEC EDGAR · filed Nov 17, 2025 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Nov 12, 2025 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Sep 3, 2025 · fetched Nov 12, 2026
- 10-Q · QUARTERLY REPORT FOR THE PERIOD ENDED JUNE 30, 2025SEC EDGAR · filed Aug 14, 2025 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Jul 31, 2025 · fetched Nov 12, 2026
- 10-K · ANNUAL REPORT FOR THE FISCAL YEAR ENDED MARCH 31, 2025SEC EDGAR · filed Jun 30, 2025 · fetched Nov 12, 2026